Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 40.17 M36.17 M31.1 M34.05 M31.15 M 132.48 M Research & development 29.05 M22.53 M22.85 M22.88 M19.61 M 87.86 M Operating income -428.93 M-44.85 M-38.88 M-41.2 M-8.36 M -133.28 M Non-Operating Income, Total 8.19 M8.1 M6.1 M5.47 M4.51 M 24.17 M Interest expense, net of interest capitalized 1.74 M1.74 M1.74 M1.74 M1.74 M 6.96 M Non-Operating Income, excl. Interest Expenses 2.16 M1.66 M1.36 M960 K760 K 4.74 M Unusual income/expense 4.29 M4.7 M3 M2.77 M2.01 M 12.47 M Pretax income -426.38 M-41.9 M-37.62 M-40.17 M-8.09 M -127.77 M Equity in earnings ————— — Taxes -302 K35 K383 K202 K184 K 804 K Non-controlling/minority interest ————— — After tax other income/expense -719 K-340 K-397 K-232 K-225 K -1.19 M Net income before discontinued operations -426.07 M-41.93 M-38 M-40.37 M-8.28 M -128.58 M Discontinued operations ————— — Net income -426.07 M-41.93 M-38 M-40.37 M-8.28 M -128.58 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -426.07 M-41.93 M-38 M-40.37 M-8.28 M -128.58 M Basic earnings per share (Basic EPS) -1.44-0.14-0.13-0.11-0.03 -0.41 Diluted earnings per share (Diluted EPS) -1.44-0.14-0.13-0.11-0.03 -0.41 Average basic shares outstanding 296.86 M300.16 M300.84 M299.96 M305.82 M — Diluted shares outstanding 296.86 M300.16 M300.84 M299.96 M305.82 M — EBITDA -53.07 M325.4 M332.2 M331.17 M-4.95 M 983.81 M EBIT -428.93 M-44.85 M-38.88 M-41.2 M-8.36 M -133.28 M Cost of revenue 38.52 M25.08 M22.54 M28.08 M24.34 M 100.04 M Other cost of goods sold 7.66 M883 K1.23 M-200 K54 K 1.96 M Depreciation & amortization (cash flow) 375.87 M370.25 M371.07 M372.37 M3.4 M 1.12 B